Search

WASHINGTON, D.C., (SEPT 14, 2023) – In joining Saul Ewing as a new partner, Jason McElroy brings 20 years of experience as a trial lawyer representing clients in federal and state courts in a wide range of matters, including consumer financial services litigation. He is resident in the firm’s...

Developing a Corporate AI Policy Join Association of Corporate Counsel, along with inside and outside counsel presenters, as they discuss implementing best practices and responsible use policies to manage the risk of utilizing AI in the workplace. Speakers: Matthew Kohel, Partner, Intellectual...

Since Elon Musk announced his decision to remove the iconic bird logo and adopt "X", as Twitter's new logo (the "X Logo"), the rebranding decision has been the talk of the town. The rollout has prompted a barrage of reactions and has many questioning whether the change will attract legal hurdles...

A recently filed class action lawsuit raises more legal challenges to providers of generative artificial intelligence (AI) tools that are used to create content. The suit cautions that a doomsday scenario is approaching and alleges a host of privacy and other violations occurring along the way. What...

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...